Role of 18F-FDG PET/CT to evaluate the effects of chimeric antigen receptor T-cell therapy on lymph node involvement in patients with non-Hodgkin lymphoma

Bimash Shrestha; Shashi Singh; William Raynor; Saira Niazi; Malia Ahmed; Miraziz Ismoilov; Niloofaralsadat Motamedi; Thomas  Werner; Mona-Elisabeth Revheim; Poul Høilund-Carlsen; Abass Alavi

Role of 18F-FDG PET/CT to evaluate the effects of chimeric antigen receptor T-cell therapy on lymph node involvement in patients with non-Hodgkin lymphoma

Bimash Shrestha
, Shashi Singh
, William Raynor
, Saira Niazi
, Malia Ahmed
, Miraziz Ismoilov
, Niloofaralsadat Motamedi
, Thomas Werner
, Mona-Elisabeth Revheim
, Poul Høilund-Carlsen
, Abass Alavi

Hospital of the University of Pennsylvania
University of Pennsylvania
Rutgers Robert Wood Johnson Medical School
Oslo University Hospital
University of Oslo

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	The Journal of Nuclear Medicine
Volume	64
Issue number	Suppl. 1
Pages (from-to)	1159
Number of pages	1
ISSN	0161-5505
Publication status	Published - 2023
Event	SNMMI 2023 Annual Meeting - McCormick Place, Chicago, United States Duration: 24. Jun 2023 → 27. Jun 2023

Conference

Conference	SNMMI 2023 Annual Meeting
Location	McCormick Place
Country/Territory	United States
City	Chicago
Period	24/06/2023 → 27/06/2023

Documents & Links

https://jnm.snmjournals.org/content/64/supplement_1/P1159

SDU Link

Check access to the material in SDU Library's search engine

Cite this

Shrestha, B., Singh, S., Raynor, W., Niazi, S., Ahmed, M., Ismoilov, M., Motamedi, N., Werner, T., Revheim, M.-E., Høilund-Carlsen, P., & Alavi, A. (2023). Role of 18F-FDG PET/CT to evaluate the effects of chimeric antigen receptor T-cell therapy on lymph node involvement in patients with non-Hodgkin lymphoma. The Journal of Nuclear Medicine, 64(Suppl. 1), 1159. https://jnm.snmjournals.org/content/64/supplement_1/P1159

@article{9e804e2072fe4398b80eebb3b520cdfd,

title = "Role of 18F-FDG PET/CT to evaluate the effects of chimeric antigen receptor T-cell therapy on lymph node involvement in patients with non-Hodgkin lymphoma",

author = "Bimash Shrestha and Shashi Singh and William Raynor and Saira Niazi and Malia Ahmed and Miraziz Ismoilov and Niloofaralsadat Motamedi and Thomas Werner and Mona-Elisabeth Revheim and Poul H{\o}ilund-Carlsen and Abass Alavi",

year = "2023",

language = "English",

volume = "64",

pages = "1159",

journal = "The Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Hellenic Society of Nuclear Medicine",

number = "Suppl. 1",

note = "SNMMI 2023 Annual Meeting ; Conference date: 24-06-2023 Through 27-06-2023",

}

Shrestha, B, Singh, S, Raynor, W, Niazi, S, Ahmed, M, Ismoilov, M, Motamedi, N, Werner, T, Revheim, M-E, Høilund-Carlsen, P & Alavi, A 2023, 'Role of 18F-FDG PET/CT to evaluate the effects of chimeric antigen receptor T-cell therapy on lymph node involvement in patients with non-Hodgkin lymphoma', The Journal of Nuclear Medicine, vol. 64, no. Suppl. 1, pp. 1159. <https://jnm.snmjournals.org/content/64/supplement_1/P1159>

Role of 18F-FDG PET/CT to evaluate the effects of chimeric antigen receptor T-cell therapy on lymph node involvement in patients with non-Hodgkin lymphoma. / Shrestha, Bimash; Singh, Shashi; Raynor, William et al.
In: The Journal of Nuclear Medicine, Vol. 64, No. Suppl. 1, 2023, p. 1159.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Role of 18F-FDG PET/CT to evaluate the effects of chimeric antigen receptor T-cell therapy on lymph node involvement in patients with non-Hodgkin lymphoma

AU - Shrestha, Bimash

AU - Singh, Shashi

AU - Raynor, William

AU - Niazi, Saira

AU - Ahmed, Malia

AU - Ismoilov, Miraziz

AU - Motamedi, Niloofaralsadat

AU - Werner, Thomas

AU - Revheim, Mona-Elisabeth

AU - Høilund-Carlsen, Poul

AU - Alavi, Abass

PY - 2023

Y1 - 2023

M3 - Conference abstract in journal

SN - 0161-5505

VL - 64

SP - 1159

JO - The Journal of Nuclear Medicine

JF - The Journal of Nuclear Medicine

IS - Suppl. 1

T2 - SNMMI 2023 Annual Meeting

Y2 - 24 June 2023 through 27 June 2023

ER -